Avisi Technologies is an ophthalmic medical device company developing novel sight-saving technologies for glaucoma treatment. The company is advancing VisiPlate®, a next-generation shunt featuring a unique metamaterial design that is thinner than a human hair and is being evaluated in the SAPPHIRE pivotal clinical trial.